Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions

Ventricular tachycardia (VT) caused by myocardial scaring bears a significant risk of mortality and morbidity. Antiarrhythmic drug therapy (AAD) and catheter ablation remain the cornerstone of VT management, but both treatments have limited efficacy and potential adverse effects. Stereotactic body r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Cardiovasc Med
Autors principals: Jumeau, Raphael, Ozsahin, Mahmut, Schwitter, Juerg, Elicin, Olgun, Reichlin, Tobias, Roten, Laurent, Andratschke, Nicolaus, Mayinger, Michael, Saguner, Ardan M., Steffel, Jan, Blanck, Oliver, Vozenin, Marie-Catherine, Moeckli, Raphael, Zeverino, Michele, Vallet, Véronique, Herrera-Siklody, Claudia, Pascale, Patrizio, Bourhis, Jean, Pruvot, Etienne
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Cardiovascular Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329991/
https://ncbi.nlm.nih.gov/pubmed/32671101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2020.00108
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars